SS Innovations International Inc. SSII Archives

TuesdayAug 18, 2026 9:00 am

SS Innovations International Inc. (NASDAQ: SSII) Record Q2 Revenue Signals Continued Momentum for SSi Mantra Robotic Surgery Platform

SS Innovations, developer of innovative surgical robotic technologies, reported record second-quarter revenue of $13.9 million, up 39.4% year over year. First-half revenue reached $25.0 million, a 65.6% increase from the same period in 2025. The company’s SSi Mantra installations rose 30.4% to 30 systems during the quarter. The installed base reached 224 SSi Mantra systems across 12 countries, with 12,272 cumulative surgeries performed. U.S. and European regulatory milestones could become important catalysts, with the company targeting FDA clearance by the first quarter of 2027 and EU CE marking by the end of 2026. The company’s telesurgery achievements are extending the…

ThursdayAug 13, 2026 10:00 am

QualityStocksNewsBreaks – SS Innovations International, Inc. (NASDAQ: SSII) Reports Record Q2 Revenue of $13.9 Million, Up 39.4%

SS Innovations International (NASDAQ: SSII) reported record second-quarter 2026 revenue of $13.9 million, up 39.4% from $10 million a year earlier, as installations of its SSi Mantra surgical robotic system increased 30.4% to 30. Gross profit rose 20% to $7.1 million, with gross margin of 50.9%, while net loss was $2.7 million, or $0.01 per diluted share, compared with a net loss of $0.3 million a year earlier. First-half revenue increased 65.6% to $25 million, while SSi Mantra installations rose 47.4% to 56. As of June 30, SS Innovations had $13.6 million in cash and cash equivalents, no long-term debt…

WednesdayAug 12, 2026 1:10 pm

QualityStocksNewsBreaks – SS Innovations International Inc. (NASDAQ: SSII) Earns Industry Recognition as SSi Mantra Adoption Expands

SS Innovations International (NASDAQ: SSII) was named the Outstanding Company at the 2026 Surgical Robotics Industry Awards, selected from 10 finalists that included several established medical technology and surgical robotics companies. The recognition comes as the company continues expanding adoption of its SSi Mantra surgical robotic platform, which had supported 11,719 procedures globally as of June 22, 2026, across more than 170 procedure types and multiple specialties. Approximately 2,100 physicians have been trained on the system, while regulatory approvals in 14 countries support the company’s international expansion strategy. SSi Mantra features a modular, multi-arm design, 3D 4K visualization and more than…

ThursdayJul 30, 2026 9:45 am

SS Innovations International Inc. (NASDAQ: SSII) Expands Global Footprint on Fast-Growing Robotic Surgery Market

The company is expanding its presence in the global surgical robotics market through its proprietary SSi Mantra robotic surgery platform. The company's strategy combines world-class robotic systems, including telesurgery capabilities, with affordability, physician training, and international market expansion. More than 200 SSi Mantra systems have been installed worldwide, supporting over 12,000 robotic procedures across more than 170 surgical indications. SS Innovations continues pursuing U.S. FDA clearance and European regulatory approvals while building its installed base internationally. Growing demand for minimally invasive surgery and broader access to robotic procedures continues to create opportunities for emerging high-tech medical technology companies. The market…

ThursdayJul 23, 2026 9:45 am

SS Innovations International Inc. (NASDAQ: SSII) to Showcase SSi Mantra Surgical Robotic System at SRS 2026 as Company Expands Global Clinical Footprint

SS Innovations will showcase its SSi Mantra surgical robotic system at the Society of Robotic Surgery (“SRS”) 2026 Annual Meeting in Florida on July 23-26. The presentation will feature a live kidney telesurgery broadcast from India, demonstrating the remote capabilities of the SSi Mantra platform. Chairman and CEO Dr. Sudhir Srivastava to participate in multiple conference presentations covering telesurgery, robotic surgery adoption and regulatory developments. As of July 6, 2026, more than 12,375 procedures have been completed using the SSi Mantra system, including cardiac, pediatric and telesurgical procedures. Approximately 2,100 physicians have already been trained on the platform, which has…

FridayJul 17, 2026 9:45 am

SS Innovations International Inc. (NASDAQ: SSII) Strengthens Leadership as Global Robotic Surgery Expansion Gains Pace

The company has appointed veteran medtech finance executive Sarah M. Romano as Chief Financial Officer, effective August 3, 2026. Romano brings more than two decades of experience in public-company finance, capital markets, and medical technology, having raised more than $100 million during her career. The appointment comes as SS Innovations continues pursuing U.S. FDA clearance for its SSi Mantra surgical robotic system while expanding internationally. The company recently graduated the inaugural class of its SS International Centre for Robotics Surgery (“SSICRS”) cardiac robotic surgery training program. SSICRS welcomed 33 healthcare professionals from seven countries, underscoring the company's emphasis on surgeon…

MondayJul 13, 2026 11:15 am

SS Innovations International Inc. (NASDAQ: SSII) CEO Outlines Strategy to Expand Affordable Robotic Surgery

Affordability and accessibility remain the company's core priorities as it expands its surgical robotics platform globally, with artificial intelligence, automation, and new robotic platforms, remaining central to the company's long-term product roadmap. Telesurgery and teleproctoring are becoming important differentiators, allowing expert surgeons to support complex procedures remotely. The SSi Mantra system was designed to reduce the cost of robotic surgery while supporting multiple specialties, including cardiac surgery. The company has installed more than 200 robotic systems and completed more than 11,700 robotic procedures, including over 170 telesurgeries. SS Innovations is pursuing FDA and European regulatory approvals while expanding into additional…

WednesdayJul 08, 2026 9:00 am

SS Innovations International Inc. (NASDAQ: SSII) Is ‘One to Watch’

Clinically validated, advanced surgical robotics technology platform. Differentiated SSi Mantra system attributes (e.g., cost advantages, cardiac and pediatric surgery capabilities, ease of use and training, and pioneering telesurgery features). Large and growing addressable market with favorable industry tailwinds. Stronghold in India, global expansion underway, and potential catalysts in the US and EU. World-class R&D and manufacturing facilities to support growth. Robust sales growth, expanding margins, and increasing mix of recurring revenue. Aligned, accomplished management team and Board of Directors. SS Innovations International (NASDAQ: SSII) develops differentiated surgical robotic technologies, highlighted by its advanced, cost-efficient SSi Mantra surgical robotic system. Spearheaded by…

TuesdayJul 07, 2026 9:30 am

QualityStocksNewsBreaks – SS Innovations International, Inc. (NASDAQ: SSII) Engages IBN for Corporate Communications

SS Innovations International (NASDAQ: SSII) has engaged IBN to support its corporate communications strategy as the company continues to advance its portfolio of surgical robotic technologies. SS Innovations' product lineup is led by its proprietary SSi Mantra surgical robotic system, which has been used in more than 11,700 procedures worldwide and is complemented by the SSi Mudra robotic instruments, SSi MantrAsana tele-surgeon console and SSi Maya mixed-reality platform. Under the agreement, IBN will leverage its investor-focused communications network, including InvestorWire and more than 5,000 syndication outlets, newsletters, social media channels and other distribution platforms, to increase awareness of SS Innovations…

MondayJul 06, 2026 1:50 pm

SS Innovations International Inc. (NASDAQ: SSII) Wins Outstanding Company at 2026 Surgical Robotics Industry Awards

The company was selected over nine other finalists, including several established medical technology companies active in robotic surgery. The award comes as adoption of the SSi Mantra surgical robotic system continues to expand, with more than 11,700 procedures completed globally. SSi Mantra has received regulatory approvals in 14 countries, supporting the company's international growth strategy. More than 2,100 physicians have been trained on the company's robotic surgery platform, which has been used across more than 170 different procedures. For investors, the recognition provides an independent industry endorsement as SS Innovations continues to expand its presence in the rapidly growing global…

Site Search

Company Search

Tag: SS Innovations International Inc. SSII